AndreaBozzo/ceres-open-data-index huggingface dataset:
Characterization of Norwalk virus GI specific monoclonal antibodies generated against

Background
          Norwalk virus causes outbreaks of acute non-bacterial gastroenteritis in humans. The virus capsid is composed of a single 60 kDa protein. In a previous study, the capsid protein of recombinant Norwalk virus genogroup II was expressed in an E. coli system and monoclonal antibodies were generated against it. The analysis of the reactivity of those monoclonal antibodies suggested that the N-terminal domain might contain more antigenic epitopes than the C-terminal domain. In the same study, two broadly reactive monoclonal antibodies were observed to react with genogroup I recombinant protein.
        
        
          Results
          In the present study, we used the recombinant capsid protein of genogroup I and characterized the obtained 17 monoclonal antibodies by using 19 overlapping fragments. Sixteen monoclonal antibodies recognized sequential epitopes on three antigenic regions, and the only exceptional monoclonal antibody recognized a conformational epitope. As for the two broadly reactive monoclonal antibodies generated against genogroup II, we indicated that they recognized fragment 2 of genogroup I. Furthermore, genogroup I antigen from a patient's stool was detected by sandwich enzyme-linked immunosorbent assay using genogroup I specific monoclonal antibody and biotinated broadly reactive monoclonal antibody.
        
        
          Conclusion
          The reactivity analysis of above monoclonal antibodies suggests that the N-terminal domain may contain more antigenic epitopes than the C-terminal domain as suggested in our previous study. The detection of genogroup I antigen from a patient's stool by our system suggested that the monoclonal antibodies generated against E. coli expressed capsid protein can be used to detect genogroup I antigens in clinical material.
Publications Using SAMHSA DataAdult Mental Health Tables (Prevalence Estimates) - 1.1 to 1.78

These detailed tables present totals and prevalence estimates of mental health related issues among adults aged 18 or older from the 2012 National Survey on Drug Use and Health (NSDUH). Tables with data on adults include measures on any mental illness (AMI), serious mental illness (SMI), moderate mental illness, low (mild) mental illness, mental health service utilization (i.e., mental health treatment or counseling), suicidal thoughts and behaviors, major depressive episode (MDE), treatment for depression (among adults with MDE), and serious psychological distress (SPD), and co-occurrence of mental disorders with substance use or with substance use disorders. Results are provided by age group, gender, race/ethnicity, education level, employment status, county type, poverty level, insurance status, overal health, and geographic area. Comparisons are made between 2012 and 2011.
Rational use of computerized protocols in the intensive care unit

Excess information in complex ICU environments exceeds human decision making limits, increasing the likelihood of clinical errors. Explicit decision-support tools have favorable effects on clinician and patient outcomes and can reduce the variation in clinical practice that persists even when guidelines based on reputable evidence are available. Computerized protocols used for complex clinical problems generate, at the point-of-care, patient-specific evidence-based therapy instructions that can be carried out by different clinicians with almost no inter-clinician variability. Individualization of patient therapy is preserved by these explicit protocols since they are driven by patient data. Computerized protocols that aid ICU decision-makers should be more widely distributed.
Compound 527799: But-2-enyl 4-chlorobenzoate

Chemical compound data from PubChem database. IUPAC Name: but-2-enyl 4-chlorobenzoate. Molecular Formula: C11H11ClO2. Molecular Weight: 210.65. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Utah (UT)

This report presents Utah\'s estimates for 25 measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Utah for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
2014 CMHS Uniform Reporting System (URS) Table for Federated States of Micronesia

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Federated States of Micronesia. The URS associated state reporting system is collected annually to support the Community Mental Health Services Block Grant program. Associated state Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
2011 CMHS Uniform Reporting System (URS) Output Tables for Virginia

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Patent AT-E400752-T1: [Translated] METHOD AND DEVICE FOR TRANSMISSION CONTROL

The invention relates to a gearbox control device comprising an input clutch which is controlled by a clutch release fork (30) and at least two shift actuators (200, 100) which each control two forward gear shifts. The invention is characterised in that the clutch release fork control shaft (50) can be moved by one of the aforementioned actuators.
Compound 530648: p-Toluic acid, 2-methyloct-5-yn-4-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2-methyloct-5-yn-4-yl 4-methylbenzoate. Molecular Formula: C17H22O2. Molecular Weight: 258.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
National Survey of Current and Former Foster Parents, 1993

The purpose of the National Survey of Current and Former Foster Parents was to collect and analyze data from a nationally representative sample of current and former foster parents that would provide direction for  future policy development.  This study used a multistage stratified design where probability sampling was employed at each stage of the design.  A mail/telephone survey was conducted of current and former foster parents in 16 counties in nine states.  Based on lists provided by the counties, 1,572 current foster parents and 362 former foster parents received a questionnaire in the mail. Follow up post cards and telephone calls were made.  The survey was designed to identify foster parent characteristics, the types of children for whom they provided care, the types of children they would be willing to care for in the future, and their interactions with the child welfare system.  An overall response rate of 71% was achieved.

Investigators: Cook, Ronna
Patent AT-E40-T1: [Translated] 2-CYCLOPROPYL-PYRIMIDIN(4 )YL-THIONOPHOSPHONE ESTERS, PROCESS FOR THEIR PRODUCTION, THEIR USE AS INSECTICIDES AND ACARICIDES, PESTICIDES CONTAINING THEM AND PROCESS FOR THEIR PRODUCTION.

Chemical patent from PubChem database. Patent Number: AT-E40-T1. Title: Pharmaceutical Salt Forms. Filing Date: 2014-01-23. Inventors: Wilson, James, Brown, Patricia, Lee, David. Abstract: Novel pharmaceutical salt forms are provided, exhibiting improved physicochemical properties including enhanced solubility, stability, and bioavailabi... IPC Classifications: C07K, A61K, G01N. This patent covers 28 claims related to 3 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Lessons learned from gene transfer approaches

Recent technological advances allow the transfer of genes to the			 synovial lining of joints. As well as opening novel opportunities for therapy,			 these techniques provide valuable new tools for the study of synovitis and			 other aspects of the biology of joints in health and disease. This article			 reviews briefly the results of experiments in which selected genes have been			 transferred to the knee joints of healthy rabbits and rabbits with			 antigen-induced arthritis.
Patent AT-E400327-T1: [Translated] ENERGY ABSORBING DEVICE

An energy absorption device for a safety fixing system includes two sections capable of being set in relative motion with friction so that the device is able to absorb energy. The device has elements for adjusting the frictional force between the two sections. A safety fixing system incorporating the energy absorption device is also disclosed. The device maybe used in the safety systems that make use, in particular, of a life-line.
Federal Fiscal Year 2022 Title IV-B, subpart 2 Funding Available to Develop and Enhance or to Evaluate Kinship Navigator Programs

This Program Instruction (PI) provides guidance to state, territorial and tribal title IV-E agencies on the actions required to apply for title IV-B, subpart 2 funding to support the development, enhancement or evaluation of kinship navigator programs.  These are federal fiscal year (FY) 2022 funds, provided in P.L. 117-103, Division H of the Consolidated Appropriations Act, 2022, enacted March 15, 2022.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 526867: 2-[2-(2-Butoxyethoxy)ethoxy]ethyl trifluoroacetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-(2-butoxyethoxy)ethoxy]ethyl 2,2,2-trifluoroacetate. Molecular Formula: C12H21F3O5. Molecular Weight: 302.29. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526588: 2,2,4,4-Tetramethyl-1,3-cyclobutane-1,3-diol, cis, bis-TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl-(2,2,4,4-tetramethyl-3-trimethylsilyloxycyclobutyl)oxysilane. Molecular Formula: C14H32O2Si2. Molecular Weight: 288.57. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2010 CMHS Uniform Reporting System (URS) Output Tables for Indiana

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Public Health Statistics - Chlamydia cases among females aged 15-44 in Chicago, by year, 2000-2014 - Historical

Note: This dataset is historical only and STI surveillance data do not change once finalized. For the most recent STI data, please refer to the CDPH Health Atlas (chicagohealthatlas.org), the annual HIV/STI surveillance report, and the Getting to Zero Illinois HIV Dashboard (gtzillinois.hiv).

The annual number of newly reported, laboratory-confirmed cases of chlamydia (Chlamydia trachomatis) among females aged 15-44 years and annual chlamydia incidence rate (cases per 100,000 females aged 15-44 years) with corresponding 95% confidence intervals by Chicago community area, for years 2000 – 2014.  See the full description by clicking on the maroon "About" button on the right-hand side of the screen, and click on the PDF under "Attachments".
Utilizing Title IV-E Funding to Support High-Quality Legal Representation and Promote Child and Family Well-Being

This Information Memorandum (IM) urges all state and tribal title IV-E agencies, courts, administrative offices of the courts, and Court Improvement Programs to work together to ensure that parents, children and youth, and child welfare agencies, receive high quality legal representation at all stages of child welfare proceedings, and to maximize allowable title IV-E administrative reimbursement for children who are candidates for title IV-E foster care or who are in title IV-E foster care and their parent(s) in foster care legal proceedings.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E401166-T1: [Translated] METHOD FOR CHECKING THE PLACEMENT OF MACHINE TOOLS AND THE PLACEMENT CHECKING DEVICE

The method involves monitoring whether an object is correctly arranged on a supporting surface in a machine tool and/or clamped by a device with first and second clamping arrangements using a line system carrying a medium and subject to pressure ending in the support surface and/or in the first clamping arrangement. The end opening of the line system is covered by the object and/or the second clamping arrangement, the pressure in the line system is reduced at a choke point, the pressure difference before and after the choke point is determined and evaluated for support control or clamping control. The cooling/lubricating liquid, an air-coolant mixture or the air-coolant flushing medium of a machine tool is used as the medium. Independent claims are also included for the following: (A) a device for object support control for a machine tool (B) and a machine tool, especially a cutting tool, with an inventive device.
Imatinib mesylate

Imatinib Mesylate is a generic prescription oral tablet medication that inhibits certain enzymes to treat conditions like chronic myeloid leukemia and gastrointestinal stromal tumors. Available in 100mg and 400mg strengths from Chartwell RX, LLC, it was approved under ANDA208429 and first marketed in 2019. This information was generated using AI and is provided for informational and research purposes only.
Tribal Federal Medical Assistance Percentage (FMAP)

The following resources provide information for tribes interested in operating title IV-E programs.

Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2026Tribal Federal Medical Assistance Percentage Reference Table for FY 2026Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2025Tribal Federal Medical Assistance Percentage Reference Table for FY 2025Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2024Tribal Federal Medical Assistance Percentage Reference Table for FY 2024Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2023Tribal Federal Medical Assistance Percentage Reference Table for FY 2023Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2022Tribal Federal Medical Assistance Percentage Reference Table for FYs 2021-2022Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2021Tribal Federal Medical Assistance Percentage Reference Table for FY 2021Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2020Tribal Federal Medical Assistance Percentage Reference Table for FY 2020Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2019Tribal Federal Medical Assistance Percentage Reference Table for FYs 2018-2019Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2018Tribal Federal Medical Assistance Percentage Reference Table for FYs 2017-2018Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2017Tribal Federal Medical Assistance Percentage Look-Up Table for FY 2016Tribal Federal Medical Assistance Percentage Reference Table for FYs 2016-2017Tribal Federal Medical Assistance Percentage Reference Table for FYs 2014-2015Tribal Federal Medical Assistance Percentage Reference Table for FYs 2013-2014

Metadata-only record linking to the original dataset. Open original dataset below.
Rates of TBI-related Emergency Department Visits, Hospitalizations, and Deaths - United States, 2001 – 2010

In general, total combined rates for traumatic brain injury (TBI)-related emergency department (ED) visits, hospitalizations and deaths have increased over the past decade.  Total combined rates of TBI-related hospitalizations, ED visits, and deaths climbed slowly from a rate of 521.0 per 100,000 in 2001 to 615.7 per 100,000 in 2005.  The rates then dipped to 595.1 per 100,000 in 2006 and 566.7 per 100,000 in 2007.  The rates then spiked sharply in 2008 and continued to climb through 2010 to a rate of 823.7 per 100,000.  Total combined rates of TBI-related hospitalizations, ED visits, and deaths are driven in large part by the relatively high number of TBI-related ED visits.  In comparison to ED visits, the overall rates of TBI-related hospitalizations remained relatively stable changing from 82.7 per 100,000 in 2001 to 91.7 per 100,000 in 2010.  TBI-related deaths also decreased slightly over time from 18.5 per 100,000 in 2001 to 17.1 per 100,000 in 2010.  Note that the axis scale for TBI-related deaths appears to the right of the chart and differs from TBI-related hospitalizations and ED visits.Go to http://www.cdc.gov/traumaticbraininjury/data/index.html to view more TBI data & statistics.
Compound 525538: Methyl 2-(4-isopropoxyphenyl)acetate

Chemical compound data from PubChem database. IUPAC Name: methyl 2-(4-propan-2-yloxyphenyl)acetate. Molecular Formula: C12H16O3. Molecular Weight: 208.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2022 National Directory of Mental Health Treatment Facilities

TheNational Directory of Mental Health Treatment Facilities - 2022is a listing of federal, state, and local government facilities and private facilities that provide mental health treatment services. It includes treatment facilities that responded to the 2021 National Substance Use and Mental Health Services Survey (N-SUMHSS). The information about each facility that appears in this Directory was provided by that facility in response to the 2021 N-SUMHSS. The N-SUMHSS is conducted annually by the Substance Abuse and Mental Health Services Administration (SAMHSA). The 2022 Directory is available in PDF and Excel formats.The Directory is ordered alphabetically by state, by city within each state, and by facility name within each city. Each facility listing includes codes that represent the services offered and other features of the facility, including codes that indicate services for hearing impaired and non-English-speaking clients. Codes are defined in a key shown on pages v-ix of the PDF file and as a separate tab on the Excel version. Because the services offered by a particular facility may change over time, it is always a good idea to verify the information in this Directory when contacting a facility.
Minneapolis: Drug-Related Emergency Department Visits, 2004-2011 - Suicide Attempts

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving suicide attempts in the Minneapolis metropolitan area, covering 2004-2011.  Drug-related suicide attempts include visits for drug overdoses and for suicide attempts by other means (e.g., using a firearm) if drugs were involved or related to the suicide attempt.
Compound 527308: Methyl 2-[2-(2,6-dichloro-4-methoxyanilino)phenyl]acetate

Chemical compound data from PubChem database. IUPAC Name: methyl 2-[2-(2,6-dichloro-4-methoxyanilino)phenyl]acetate. Molecular Formula: C16H15Cl2NO3. Molecular Weight: 340.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401381-T1: [Translated] LIQUID CRYSTALLINE INTERPENETRATING POLYMER NETWORKS

A photovoltaic cell is provided. The photovoltaic cell can be an interconnecting liquid crystalline polymer network. Reactive mesogens of the formula B-S-A-S-B wherein A is a chromophore, S is a spacer and B is an end group susceptible to polymerization are used in the manufacture of the interconnecting liquid crystalline polymer network.
Obstructive sleep apnea and vascular disease

There is emerging evidence linking obstructive sleep apnea (OSA) to vascular disease, including hypertension. This relationship may be independent of co-morbidity, such as obesity. Even apparently healthy OSA patients have evidence of subtle functional vascular abnormalities that are known to occur in patients with hypertension and atherosclerosis. Untreated OSA may possibly contribute to the initiation and/or progression of pathophysiologic mechanisms involved in hypertension, heart failure, cardiac ischemia and stroke. This brief commentary will examine the evidence and mechanisms linking OSA to vascular disease.
Florida (FL)

This report presents estimates for measures of substance use and mental health based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Florida for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
COVID-19 State Profile Report - Maine

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
Compound 526511: 2-Isothiocyanato-4-methylpentanoic acid ethyl ester

Chemical compound data from PubChem database. IUPAC Name: ethyl 2-isothiocyanato-4-methylpentanoate. Molecular Formula: C9H15NO2S. Molecular Weight: 201.29. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.